# Effect of Midodrine on HVPG in Advanced Chronic Liver Disease

> **NCT04455464** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 60 (actual)

## Conditions studied

- Chronic Liver Disease

## Interventions

- **DRUG:** Midodrine Oral Tablet

## Key facts

- **NCT ID:** NCT04455464
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-11
- **Primary completion:** 2021-12-13
- **Final completion:** 2021-12-13
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04455464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04455464, "Effect of Midodrine on HVPG in Advanced Chronic Liver Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04455464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*